5843 related articles for article (PubMed ID: 2508254)
1. Immunoreactivity of tissue plasminogen activator and of its inhibitor complexes. Biochemical and multicenter validation of a two site immunosorbent assay.
Rånby M; Nguyen G; Scarabin PY; Samama M
Thromb Haemost; 1989 Jun; 61(3):409-14. PubMed ID: 2508254
[TBL] [Abstract][Full Text] [Related]
2. Characterization of monoclonal antibodies against human tissue plasminogen activator (tPA): quantitation of free tPA in human cell cultures by an ELISA.
Kurokawa T; Toyoda Y; Iwasa S
J Biochem; 1991 Feb; 109(2):217-22. PubMed ID: 1713912
[TBL] [Abstract][Full Text] [Related]
3. Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.
Grebenchtchikov N; Maguire TM; Riisbro R; Geurts-Moespot A; O'Donovan N; Schmitt M; McGreal G; McDermott E; O'Higgins N; Brünner N; Sweep CG; Duffy MJ
Oncol Rep; 2005 Jul; 14(1):235-9. PubMed ID: 15944795
[TBL] [Abstract][Full Text] [Related]
4. Distribution of tissue-type plasminogen activator (activity and antigen) in rat tissues.
Padró T; van den Hoogen CM; Emeis JJ
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):601-8. PubMed ID: 2133239
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activators and their inhibitors in human saliva and salivary gland tissue.
Virtanen OJ; Sirén V; Multanen J; Färkkilä M; Leivo I; Vaheri A; Koskiniemi M
Eur J Oral Sci; 2006 Feb; 114(1):22-6. PubMed ID: 16460337
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
Wojta J; Turcu L; Wagner OF; Korninger C; Binder BR
J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431
[TBL] [Abstract][Full Text] [Related]
7. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ
Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427
[TBL] [Abstract][Full Text] [Related]
8. Tissue plasminogen activator (tPA) antigen in plasma: correlation with different tPA/inhibitor complexes.
Nordenhem A; Wiman B
Scand J Clin Lab Invest; 1998 Oct; 58(6):475-83. PubMed ID: 9832339
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the regulation of urokinase and tissue type plasminogen activators by the serpin, protein C inhibitor, in semen and blood plasma.
España F; Estellés A; Fernández PJ; Gilabert J; Sánchez-Cuenca J; Griffin JH
Thromb Haemost; 1993 Dec; 70(6):989-94. PubMed ID: 8165623
[TBL] [Abstract][Full Text] [Related]
10. A monoclonal antibody that does not recognize tissue-type plasminogen activator bound to its naturally occurring inhibitor.
Schleef RR; Wagner NV; Sinha M; Loskutoff DJ
Thromb Haemost; 1986 Dec; 56(3):328-32. PubMed ID: 2436333
[TBL] [Abstract][Full Text] [Related]
11. Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis.
Björquist P; Ehnebom J; Inghardt T; Hansson L; Lindberg M; Linschoten M; Strömqvist M; Deinum J
Biochemistry; 1998 Feb; 37(5):1227-34. PubMed ID: 9477948
[TBL] [Abstract][Full Text] [Related]
12. Assay of human tissue-type plasminogen activator (t-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PA.
Holvoet P; Cleemput H; Collen D
Thromb Haemost; 1985 Oct; 54(3):684-7. PubMed ID: 3937265
[TBL] [Abstract][Full Text] [Related]
13. [Study on fibrinolysis and platelet function].
Deguchi K; Murashima S; Nishikawa M; Shirakawa S
Nihon Rinsho; 1992 Feb; 50(2):297-302. PubMed ID: 1613983
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody-based immunoassays for the specific quantitation of rat PAI-1 antigen and activity in biological samples.
Ngo TH; Verheyen S; Knockaert I; Declerck PJ
Thromb Haemost; 1998 Apr; 79(4):808-12. PubMed ID: 9569197
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of a functionally active tPA-like plasminogen activator in human platelets.
Wang DL; Pan YT; Wang JJ; Cheng CH; Liu CY
Thromb Haemost; 1994 Apr; 71(4):493-8. PubMed ID: 8052969
[TBL] [Abstract][Full Text] [Related]
16. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
[TBL] [Abstract][Full Text] [Related]
17. Effects of octreotide on epidermal growth factor receptor, tissue plasminogen activator, and plasminogen activator inhibitor during intraperitoneal adhesion formation.
Lai HS; Chen Y; Chang KJ; Chen WJ
J Gastroenterol; 2003; 38(6):555-60. PubMed ID: 12825131
[TBL] [Abstract][Full Text] [Related]
18. A sensitive ELISA for human tissue-type plasminogen activator applicable to the study of acute release from cultured human endothelial cells.
Schrauwen Y; Emeis JJ; Kooistra T
Thromb Haemost; 1994 Feb; 71(2):225-9. PubMed ID: 8191403
[TBL] [Abstract][Full Text] [Related]
19. Immunoassays for the quantitation of porcine PAI-1 antigen and activity in biological fluid samples.
Leng HM; Brouwers E; Knockaert I; Declerck PJ
Thromb Haemost; 2000 Dec; 84(6):1082-6. PubMed ID: 11154117
[TBL] [Abstract][Full Text] [Related]
20. A quantitative ELISA for the measurement of complexes of prostate-specific antigen with protein C inhibitor when using a purified standard.
España F; Sanchez-Cuenca J; Vera CD; Estelles A; Gilabert J
J Lab Clin Med; 1993 Dec; 122(6):711-9. PubMed ID: 7504042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]